ISPOR Publishes Report on Health Economics and Outcomes Research in Low- and Middle-Income Countries

Published May 22, 2023

LMIC Report CoverLawrenceville, NJ, USA—May 22, 2023—ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR) announced today that it has published a new report on its work in low- and middle-income countries (LMICs). The report, “Advancing HEOR in Low- and Middle-Income Countries,” explores the distinctive needs LMICs have in developing their HEOR capacity, as well as the Society’s work to fulfill its mission to promote HEOR excellence to improve decision making for health globally in these regions.

ISPOR has a strong commitment to the advancement of HEOR in LMICs. More than 20% of the Society’s members, 65% of ISPOR regional chapters, and 35% of ISPOR student chapters are in LMICs. The report notes that LMICs face unique healthcare system challenges, “including limited resources for healthcare, gaps in human and infrastructure capacity, often fragmented systems, and growing burden of disease.”

Much of ISPOR’s work in LMICs is focused on supporting critical HEOR capacity building in these countries, through education and training. The Society also provides publishing opportunities for researchers in LMICs, chapter support, conference grants, educational funding, fee-waived membership grants, HEOR awards and more. Additional information can be found on the Society’s Advancing HEOR in Low- and Middle Income Countries webpage.

###


ABOUT ISPOR
ISPOR—The Professional Society for Health Economics and Outcomes Research (HEOR), is an international, multistakeholder, nonprofit dedicated to advancing HEOR excellence to improve decision making for health globally. The Society is the leading source for scientific conferences, peer-reviewed and MEDLINE®-indexed publications, good practices guidance, education, collaboration, and tools/resources in the field.
Website  | LinkedIn  | Twitter (@ispororg)  |  YouTube  |  Facebook  |  Instagram 

Related Stories

The Ozempic Paradox: How Spending Billions on Weight-Loss Drug Would Actually Reduce Overall Medicare Costs

Oct 14, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a landmark study by researchers at the University of Washington, Curta, Inc, and the University of North Carolina showing that broad Medicare coverage of semaglutide in diabetes, obesity, and liver disease could generate significant cost savings while delivering substantial health benefits to beneficiaries. The report, “Comprehensive Access to Semaglutide: Clinical and Economic Implications for Medicare,” was published in the October 2025 issue of Value in Health.

ISPOR Europe 2025 Plenaries and Speakers Announced

Oct 13, 2025

ISPOR announced details for its ISPOR Europe 2025. The conference is the leading global conference in Europe for health economics and outcomes research (HEOR) and is scheduled for 9-12 November in Glasglow, Scotland, UK with the theme, “Powering Value and Access Through Patient-Centered Collaboration.”
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×